| Favourites |

FAQ

General

Assigned items: 2

Paid Subscription

Assigned items: 4

Free Subscription

Assigned items: 2

News Letter

Assigned items: 2

Newsletter

BioMedReports Ocata Successfully Completes Dosing in Phase 1/2 RPE Studies; Capricor Completes Enrollment of canada pharmacy Phase II Clinic... http://t.co/7X8xL6MZv7
4hreplyretweetfavorite
BioMedReports Can Fite Biopharma Ltd (ADR) NYSEMKT CANF) Slumps On Drug Trial Failure: Biotechnology Company Can Fite Bioph... http://t.co/uJyi3bOgmN
9hreplyretweetfavorite
BioMedReports Orexigen Therapeutics, Inc. (NASDAQ:OREX) stock surges as Mysimba gets European approval: Orexigen Therapeuti... http://t.co/kx3IQxiSKV